Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
JPRN |
Last refreshed on:
|
17 October 2023 |
Main ID: |
JPRN-UMIN000010752 |
Date of registration:
|
17/05/2013 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia.
|
Scientific title:
|
A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia. - Donepezil study on Parkinson\'s disease with dementia |
Date of first enrolment:
|
2013/05/17 |
Target sample size:
|
50 |
Recruitment status: |
Complete: follow-up complete |
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012567 |
Study type:
|
Interventional |
Study design:
|
Single arm Non-randomized
|
Phase:
|
Not selected
|
|
Countries of recruitment
|
Japan
| | | | | | | |
Contacts
|
Name:
|
Satoshi Kaneko |
Address:
|
2-5-1 Shinmachi, Hirakata
Japan |
Telephone:
|
072-804-2542 |
Email:
|
kanekosa@takii.kmu.ac.jp |
Affiliation:
|
Kansai Medical University Department of Neurology |
|
Name:
|
Satoshi Kaneko |
Address:
|
2-5-1 Shinmachi, Hirakata
Japan |
Telephone:
|
072-804-2542 |
Email:
|
kanekosa@takii.kmu.ac.jp |
Affiliation:
|
Kansai Medical University Department of Neurology |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: 1)Patients or their families disagreed to this study 2)Who have been already treated with anti-dementia drugs. 3)Past medical history of severe neurological or psychological disorders (brain tumor, schizophrenia, epilepsy, normal pressure hydrocephalus, mental retardation, head injury associated with loss of consciousness, neurosurgery with residual symptoms). 4)Who have been regarded to be inappropriate to participate in the study.
Age minimum:
Not applicable
Age maximum:
Not applicable
Gender:
Male and Female
|
Health Condition(s) or Problem(s) studied
|
Parkinson's disease
|
Intervention(s)
|
donepezil
|
Primary Outcome(s)
|
UPDRS,MMSE
|
Source(s) of Monetary Support
|
Kansai Medical University
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
Results
|
Results available:
|
Yes |
Date Posted:
|
|
Date Completed:
|
16/05/2015 |
URL:
|
|
|
|